Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

F:GU5

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is GU5's stock price target?

Price Target

2.5 EUR

According to Wall Street analysts, the average 1-year price target for GU5 is 2.5 EUR with a low forecast of 1.54 EUR and a high forecast of 3.54 EUR.

What is the Revenue forecast for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd?

Projected CAGR

5%

Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 3 years is 5%.

What is the Gross Profit forecast for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd?

Projected CAGR

5%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 2 years is 5%.

What is the Operating Income forecast for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd?

Projected CAGR

8%

Over the last 13 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 8%.

What is the Pre-Tax Income forecast for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd?

Projected CAGR

7%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 7%.

What is the Net Income forecast for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd?

Projected CAGR

7%

Over the last 13 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 7%.